极光激酶B：癌症中一个新的有前景的治疗靶点。
Aurora B: A new promising therapeutic target in cancer.
作者信息
Chieffi Paolo
机构信息
Dipartimento di Psicologia, Università della Campania, Caserta, Italy.
出版信息
Intractable Rare Dis Res. 2018 May;7(2):141-144. doi: 10.5582/irdr.2018.01018.
Abstract
A critical step for maintenance of genetic stability is chromosome segregation, which requires a high coordination of cellular processes. Loss of mitotic regulation is a possible cause of aneuploidy in human epithelial malignancy and it is thought to create an abnormal nuclear morphology in cancer cells. Serine/threonine protein kinase Aurora B gene plays a regulatory role from G2 to cytokinesis, encompassing key cell cycle events such as centrosome duplication, chromosome bi-orientation, and segregation. The overexpression of Aurora B has been observed in several tumour types, and has been linked with a poor prognosis for cancer patients. Therapeutic inhibition of Aurora kinase showed great promise as a probable anticancer regime because of its important role during cell division.
摘要
维持遗传稳定性的关键步骤是染色体分离，这需要细胞过程的高度协调。有丝分裂调控的丧失是人类上皮恶性肿瘤中非整倍体的一个可能原因，并且被认为会在癌细胞中产生异常的核形态。丝氨酸/苏氨酸蛋白激酶Aurora B基因在从G2期到胞质分裂的过程中发挥调节作用，涵盖了诸如中心体复制、染色体双定向和分离等关键细胞周期事件。在几种肿瘤类型中都观察到了Aurora B的过表达，并且它与癌症患者的不良预后有关。由于Aurora激酶在细胞分裂过程中的重要作用，对其进行治疗性抑制作为一种可能的抗癌方案显示出了巨大的前景。
相似文献
1
Aurora B: A new promising therapeutic target in cancer.极光激酶B：癌症中一个新的有前景的治疗靶点。
Intractable Rare Dis Res. 2018 May;7(2):141-144. doi: 10.5582/irdr.2018.01018.
2
Mitotic kinases: the key to duplication, segregation, and cytokinesis errors, chromosomal instability, and oncogenesis.有丝分裂激酶：复制、分离、胞质分裂错误、染色体不稳定及肿瘤发生的关键因素。
Pharmacol Ther. 2006 Sep;111(3):974-84. doi: 10.1016/j.pharmthera.2006.02.006. Epub 2006 Apr 17.
3
Aurora B: a new prognostic marker and therapeutic target in cancer.极光 B：癌症的一个新预后标志物和治疗靶点。
Curr Med Chem. 2011;18(4):482-96. doi: 10.2174/092986711794480203.
4
[The function of Aurora A and its role in the development of liver cancer].[极光激酶A的功能及其在肝癌发生发展中的作用]
Zhonghua Gan Zang Bing Za Zhi. 2017 Jun 20;25(6):477-480. doi: 10.3760/cma.j.issn.1007-3418.2017.06.019.
5
Aurora kinases in spindle assembly and chromosome segregation.极光激酶在纺锤体组装和染色体分离中的作用
Exp Cell Res. 2004 Nov 15;301(1):60-7. doi: 10.1016/j.yexcr.2004.08.016.
6
Aurora kinase inhibitors in preclinical and clinical testing.处于临床前和临床试验阶段的极光激酶抑制剂。
Expert Opin Investig Drugs. 2009 Apr;18(4):379-98. doi: 10.1517/13543780902806392.
7
The Aurora kinases: role in cell transformation and tumorigenesis.极光激酶：在细胞转化和肿瘤发生中的作用。
Cancer Metastasis Rev. 2003 Dec;22(4):451-64. doi: 10.1023/a:1023789416385.
8
Function and regulation of Aurora/Ipl1p kinase family in cell division.极光激酶/Aurora/Ipl1p激酶家族在细胞分裂中的功能与调控
Cell Res. 2003 Apr;13(2):69-81. doi: 10.1038/sj.cr.7290152.
9
Aurora kinases: new molecular targets in thyroid cancer therapy.极光激酶：甲状腺癌治疗中的新分子靶点。
Clin Ter. 2012 Nov;163(6):e457-62.
10
Aurora Kinase Inhibitors: Current Status and Outlook.极光激酶抑制剂：现状与展望
Front Oncol. 2015 Dec 21;5:278. doi: 10.3389/fonc.2015.00278. eCollection 2015.
引用本文的文献
1
Machine Learning-Assisted Drug Repurposing Framework for Discovery of Aurora Kinase B Inhibitors.用于发现极光激酶B抑制剂的机器学习辅助药物再利用框架
Pharmaceuticals (Basel). 2024 Dec 25;18(1):13. doi: 10.3390/ph18010013.
2
Preserving Genome Integrity: Unveiling the Roles of ESCRT Machinery.维持基因组完整性：揭示 ESCRT 机器的作用。
Cells. 2024 Aug 5;13(15):1307. doi: 10.3390/cells13151307.
3
Centrosomes and associated proteins in pathogenesis and treatment of breast cancer.中心体及其相关蛋白在乳腺癌发病机制与治疗中的作用
Front Oncol. 2024 Mar 28;14:1370565. doi: 10.3389/fonc.2024.1370565. eCollection 2024.
4
LINC01134: a pivotal oncogene with promising predictive maker and therapeutic target in hepatocellular carcinoma.LINC01134：一种在肝细胞癌中具有前景的预测标志物和治疗靶点的关键致癌基因。
Front Oncol. 2024 Feb 21;14:1265762. doi: 10.3389/fonc.2024.1265762. eCollection 2024.
5
Hepatitis C virus fitness can influence the extent of infection-mediated epigenetic modifications in the host cells.丙型肝炎病毒的适应性可以影响感染介导的宿主细胞内表观遗传修饰的程度。
Front Cell Infect Microbiol. 2023 Mar 13;13:1057082. doi: 10.3389/fcimb.2023.1057082. eCollection 2023.
6
Pediatric Acute Lymphoblastic Leukemia Emerging Therapies-From Pathway to Target.儿科急性淋巴细胞白血病的新兴疗法-从通路到靶点。
Int J Mol Sci. 2023 Feb 28;24(5):4661. doi: 10.3390/ijms24054661.
7
A Review of the Regulatory Mechanisms of N-Myc on Cell Cycle.N-Myc 对细胞周期调控机制的研究综述。
Molecules. 2023 Jan 23;28(3):1141. doi: 10.3390/molecules28031141.
8
The deubiquitinating enzyme complex BRISC regulates Aurora B activation via lysine-63-linked ubiquitination in mitosis.去泛素化酶复合物 BRISC 通过有丝分裂中赖氨酸 63 位连接的泛素化调节 Aurora B 的激活。
Commun Biol. 2022 Dec 6;5(1):1335. doi: 10.1038/s42003-022-04299-4.
9
The Abscission Checkpoint: A Guardian of Chromosomal Stability.细胞分裂后期检查点：染色体稳定性的守护者。
Cells. 2021 Nov 29;10(12):3350. doi: 10.3390/cells10123350.
10
Synthesis, In Vitro and In Silico Anticancer Activity of New 4-Methylbenzamide Derivatives Containing 2,6-Substituted Purines as Potential Protein Kinases Inhibitors.新型含 2,6-取代嘌呤的 4-甲基苯甲酰胺衍生物的合成、体外及计算机抗肿瘤活性研究作为潜在的蛋白激酶抑制剂。
Int J Mol Sci. 2021 Nov 25;22(23):12738. doi: 10.3390/ijms222312738.
本文引用的文献
1
An up-date on epigenetic and molecular markers in testicular germ cell tumors.睾丸生殖细胞肿瘤中表观遗传学和分子标志物的最新进展。
Intractable Rare Dis Res. 2017 Nov;6(4):319-321. doi: 10.5582/irdr.2017.01070.
2
A comprehensive review on Aurora kinase: Small molecule inhibitors and clinical trial studies.关于极光激酶的全面综述：小分子抑制剂与临床试验研究
Eur J Med Chem. 2017 Nov 10;140:1-19. doi: 10.1016/j.ejmech.2017.08.045. Epub 2017 Aug 24.
3
New perspective on molecular markers as promising therapeutic targets in germ cell tumors.分子标志物作为生殖细胞肿瘤有前景的治疗靶点的新视角。
Intractable Rare Dis Res. 2016 May;5(2):137-9. doi: 10.5582/irdr.2016.01007.
4
D-Aspartate Induces Proliferative Pathways in Spermatogonial GC-1 Cells.D-天冬氨酸诱导精原细胞GC-1细胞的增殖途径。
J Cell Physiol. 2016 Feb;231(2):490-5. doi: 10.1002/jcp.25095.
5
High levels of GPR30 protein in human testicular carcinoma in situ and seminomas correlate with low levels of estrogen receptor-beta and indicate a switch in estrogen responsiveness.人原位睾丸癌和精原细胞瘤中高水平的GPR30蛋白与低水平的雌激素受体β相关，并表明雌激素反应性发生了转变。
J Cell Physiol. 2015 Jun;230(6):1290-7. doi: 10.1002/jcp.24864.
6
Recent advances in molecular and cell biology of testicular germ-cell tumors.睾丸生殖细胞肿瘤的分子和细胞生物学研究进展。
Int Rev Cell Mol Biol. 2014;312:79-100. doi: 10.1016/B978-0-12-800178-3.00003-8.
7
Molecular biomarkers as potential targets for therapeutic strategies in human testicular germ cell tumors: an overview.分子生物标志物作为人类睾丸生殖细胞肿瘤治疗策略的潜在靶点：综述。
J Cell Physiol. 2013 Aug;228(8):1641-6. doi: 10.1002/jcp.24328.
8
The high-mobility group A1-estrogen receptor β nuclear interaction is impaired in human testicular seminomas.高迁移率族蛋白 A1-雌激素受体β核相互作用在人睾丸精原细胞瘤中受损。
J Cell Physiol. 2012 Dec;227(12):3749-55. doi: 10.1002/jcp.24087.
9
Down-regulation of oestrogen receptor-β associates with transcriptional co-regulator PATZ1 delocalization in human testicular seminomas.雌激素受体-β下调与人类睾丸精原细胞瘤中转录共调节因子 PATZ1 易位相关。
J Pathol. 2011 May;224(1):110-20. doi: 10.1002/path.2846. Epub 2011 Mar 7.
10
Aurora B: a new prognostic marker and therapeutic target in cancer.极光 B：癌症的一个新预后标志物和治疗靶点。
Curr Med Chem. 2011;18(4):482-96. doi: 10.2174/092986711794480203.
Zotero 插件